Top Markets
#1 TENDIES TENDIES +31.93%
#2 Cash Cat Cash Cat +17.71%
#3 OSK OSK +15.33%
#4 Seeker Seeker +8.17%
#5 Tornado Cash Tornado Cash +6.73%
#6 Big Time Big Time +6.31%
#7 Nesa Nesa +6.00%
#8 UnifAI Network UnifAI Network +5.06%
#9 Staked ZIG Staked ZIG +4.30%
#10 Jelly-My-Jelly Jelly-My-Jelly +4.11%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Clasificación en acciones #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Precio por acción
$3.78
Última sincronización: 2026-03-17
Capitalización bursátil
$276.54M
Cambio (1 día)
0.00%
Cambio (1 año)
45.53%
País
CA
Comercio NervGen Pharma Corp. (NGEN)

Categoría

Healthcare
Ganancias de NervGen Pharma Corp. (NGEN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di NervGen Pharma Corp., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de NervGen Pharma Corp. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH